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In patients with gastric cancer, metastasis to the
lymph nodes is considered to be one of the most
important predictive factors in the prognosis
(Kaibara et al., 1988; Maruyama et al., 1989).
Histological nodal metastasis is examined rou-
tinely by conventional hematoxylin-eosin (HE)
staining.  However, discrete cancer cells or
small clusters of cancer cells within the nodes,
namely, micrometastases, are easily overlooked
after HE staining (Ishida et al., 1997; Sasaki et
al., 1997).  Immunostaining for cytokeratin
(CK), using the monoclonal antibody CAM 5.2,
is a very sensitive method for the detection of
such micrometastases when cancers have de-
veloped from epithelial tissues (Makin and
Bodmer, 1984; Sedmak et al., 1989; Maehara et
al., 1996a, 1996b; Ishida et al., 1997; Sasaki et
al., 1997).
Lymph nodes around the abdominal aorta
are the furthest from the primary gastric lesion
in the abdominal cavity.  These paraaortic
nodes are classified as most-distant group 4
(N4) in the Japanese system for classification of
gastric cancer (Japanese Research Society for
Gastric Cancer, 1993).  We previously conduct-
ed a prospective study to compare morbidity,
mortality and survival, from May 1990 to April
1997, between conventional extended D3 lym-
phadenectomy and super-extended D3 plus
paraaortic lymphadenectomy (PAL; Yonemura
et al., 1991).  In the current study, we examined
all lymph nodes by immunostaining for CK in
patients who had been diagnosed as having no
nodal metastasis by HE staining in our earlier
prospective study.  The purpose of this study
was to evaluate the clinical implications of CK-
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Detection of occult metastases in lymph nodes by immunostaining is becoming of increas-
ing interest as a way to improve the accuracy of predicting the prognosis for patients
with gastric cancer.  Immunohistochemical detection of cytokeratin (CK) is recognized
as the most sensitive method for identification of cancerous epithelial cells.  In this
study, lymph nodes were stained for CK in an effort to detect micrometastases and the
clinical implications of the results were examined.  We immunostained sections from a
total of 1,198 lymph nodes from 25 totally gastrectomized patients with T3 or T4 gastric
cancer who had been diagnosed as having no nodal involvement by conventional
hematoxylin-eosin (HE) staining.  Eighty (6.7%) of 1,198 lymph nodes from 15 (60%)
of the 25 patients were immunostained with a CK-specific monoclonal antibody.  CK-
positive cells were more frequent in patients with macroscopic types of 3,4 and 5 gastric
cancer.  Patients with nodes that were both HE-negative and CK-negative had the best
postoperative survival, followed by patients with HE-negative and CK-positive nodes
and, finally, by patients with HE-positive nodes.  Our results indicate that the presence
of micrometastases in lymph nodes is a reliable indicator of the prognosis of patients
with advanced gastric cancer.
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positive cells in apparently metastasis-negative
nodes.
Patients and Methods
Patients
Between May 1990 and April 1997, 70 patients
were entered into a prospective study after pre-
operative informed consent had been obtained.
The eligibility requirements for inclusion in the
study were as follows.  Patients had to be under
75 years of age without other malignancies in
organs other than the stomach.
After laparotomy, we also excluded patients
with peritoneal seeding or liver metastasis, as
well as those who had macroscopic metastases
in the paraaortic lymph nodes.  Patients who
had T3 (serosal invasion) or T4 (invasion of
adjacent structures) gastric cancer and who had
undergone potentially curative total gastrec-
tomy were entered into the study after extended
dissection of group 1 (N1), group 2 (N2) and
group 3 (N3) lymph nodes, namely, the D3 pro-
cedure.  The extent of lymphadenectomy was
expressed as follows:  D1, complete removal of
N1 nodes; D2, complete removal of N1 and N2
nodes; D3, complete removal of N1, N2 and N3
nodes; and D3 plus PAL, complete removal of
N1, N2 and N3 nodes, as well as paraaortic lym-
phadenectomy.  The 70 patients were divided,
by alternate designation at the time of opera-
tion, into the D3 (n = 35) and D3 plus PAL (n =
35) groups.
Methods
All dissected lymph nodes were prepared for
histologic analysis by one central cross-
sectional passage through the hilus for micro-
scopic examination of metastasis.  Among 70
patients, 25 were diagnosed, after HE staining,
as having no metastasis in all dissected nodes
(12 of the 35 patients in the D3 group and 13 of
the 35 patients in the D3 plus PAL group).  In
the present study, we examined a total of 1,198
nodes, consisting of 1,024 nodes (mean 41
nodes per patient) in groups N1, N2 and N3 and
174 nodes (mean 13 nodes per patient) in group
N4 (paraaortic nodes) from these 25 node-
negative patients.
Paraffin-embedded blocks of the 1,198
lymph nodes and the 25 primary gastric tumors
were prepared from the above mentioned 25 pa-
tients.  Serial sections of 4 µm in thickness were
prepared from the blocks and subjected to HE
staining and CK-specific immunostaining to
allow comparison of results obtained by the 2
methods in adjacent sections of each lymph
node and in the primary gastric tumor.
Immunohistochemical staining was per-
formed by the streptavidin-biotin method with a
murine monoclonal antibody, CAM 5.2 (Becton
Dickinson, San Jose, CA) against low-molecular-
weight CK.  In brief, dewaxed and dehydrated
sections were heated in a microwave oven (700
W) for 10 min for retrieval of antigens in the spec-
imens.  Endogenous peroxidase was blocked by
incubation of samples with 3% hydrogen perox-
ide in 100% methanol.  The tissue sections were
then incubated with the primary antibody CAM
5.2 at 25 µg per mL overnight at 4˚C.  The
second antibodies, biotinylated antibodies
against mouse immunoglobulin, were applied,
and sections were then incubated with perox-
idase-labeled streptavidin.  Reaction products
were visualized with diaminobenzidine as the
chromogen, and sections were counterstained
with methyl green for visualization of lympho-
cytes.  Tris-buffered saline was used instead of
the primary antibody for negative controls.
The lymph nodes were divided into 5 CK-
groups according to the criteria defined by
Ishida and colleagues (1997):  CK-group 0 (CG
0), no cancer cells in the section of the node;
CK-group 1 (CG 1), only 1 discrete cancer cell
in the section of the node (Figs. 1a and b); CK-
group 2 (CG 2), 2 or more discrete but not
aggregated cancer cells in the section of the
node; CK-group 3 (CG 3), in addition to dis-
crete cancer cells, 1 or more aggregates of 2 or
more cancer cells in the section; and CK-group
4 (CG 4), metastasized cells detectable by
standard HE staining (Figs. 1c and 1d).  The
determination of the CK-group for each patient
was based on the highest group recorded for any
of that patient’s lymph nodes.
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Fig. 1.  Examples of stained lymph nodes after staining with hematoxylin-eosin (HE) and after immuno-
staining specific for cytokeratin (CK).  a and b: a discrete cancer cell is hard to identify after HE staining (a)
but is readily identifiable after CK-specific immunostaining (b) (× 95).  c and d: aggregated cancer cells are
recognized after both HE staining (c) and immunostaining with CK (d) (× 48).
a b
c d
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Statistical analysis was performed by the
chi-squared test.  The Kaplan-Meier method
was used to calculate cumulative survival
curves and the generalized Wilcoxon test was
used for examination of the statistical signifi-
cance of differences.  A P value of less than
0.05 was considered to be statistically signifi-
cant.
Results
A total of 1,198 lymph nodes from 25 patients
with advanced gastric cancer were examined in
this study.  All 25 primary tumors were consis-
tently immunostained with the monoclonal
antibody against CK.  No CK-positive nodes
were found in 10 of the 25 patients, while 15
patients (60%) had CK-positive nodes.  After
the results of immunostaining had been record-
ed, all HE-stained samples were reexamined,
and 6 cases (seven lymph nodes) in which meta-
stasized cancer cells had been recognized on
HE-stained slides were classified as CG 4.  It
was difficult to identify metastatic cells on
other HE-stained slides from 19 patients (a total
of 73 nodes), even when CK-positive cells had
been detected by immunostaining. We divided
our cases into 5 CK-groups, CG 0, CG 1, CG 2,
CG 3 and CG 4, and there were 10, 2, 4, 3 and 6
patients in each group, respectively (Table 1).
Among 1,198 lymph nodes, 80 lymph nodes
(6.7%) from a total of 15 patients were immu-
nopositive for CK, as shown in Table 2.
The cytoplasm of immunopositive cells was
diffusely stained and products of the immuno-
reaction were visualized as brown circles that
were due to staining by diaminobenzidine.  The
nuclei of such cells were barely stained.
Relationships between the presence of CK-
positive nodes and the clinicopathological fea-
tures of primary tumors are shown in Table 3.
Table 1. Incidence of CK-positive lymph nodes in 25 patients with nodes in which metastases
were undetectable after HE staining
 Number                  CK-negative                                                            CK-positive
     of
patients CG 0 CG 1 CG 2 CG 3 CG4
25 10 2 4 3 6
(100) (40) (8) (16) (12) (24)
                                                                                                                    15 (60)
(   ), percentage.
CG 0, no cancer cells in the sections of lymph nodes; CG 1, only 1 discrete cancer cell; CG 2, 2 or more discrete
but not aggregated  cancer cells; CG 3, in addition to discrete cancer cells, 1 or more aggregates of 2 or more
cancer cells; CG 4, metastasized cells detectable by standard HE staining; CK, cytokeratin; HE, hematoxylin-
eosin.
Table 2.  Number and classification of CK-positive lymph nodes among 1,198 nodes from 25
patients
 Number of CG 0 CG 1 CG 2 CG 3 CG4
lymph nodes
1,198 1118 40 28 5 7
(100) (93.3) (3.3) (2.3) (0.4) (0.6)
                                                                                                                    80 (6.7)
(   ), percentage.
CG 0–4, see footnote to Table 1; CK, cytokeratin.
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We found no significant relationships between
the presence of CK-positive nodes and the size
of the tumor, the histological type, the depth of
tumor invasion, and lymphatic or blood-vessel
invasion by the primary lesion.  However, the
incidence of CK-positive nodes was signifi-
cantly higher in patients with macroscopic
types of 3, 4 and 5 gastric cancer (Table 3).
Table 4 shows the numbers and CG-groups
of CK-positive nodes in terms of the sites of im-
munopositive lymph nodes.  CK-positive nodes
were found most frequently among lymph
nodes along the greater curvature (18 nodes),
followed by lymph nodes along the lesser
curvature (17 nodes), infrapyloric nodes (12
nodes), and right cardial nodes (10 nodes).
Lymph nodes in group N1 included the largest
number of CK-positive nodes followed by
group N2.  No CK-positive nodes were found in
lymph nodes in groups N3 and N4.
The relationship between CK-positive
nodes and postoperative survival of patients is
shown in Fig. 2.  To indicate the survival of
control patients, we have included in Fig. 2 the
survival of 45 of the 70 patients in our prospec-
tive study.  These 45 patients had been diagnos-
ed as having HE-detectable nodal involvement
(therefore, lymph nodes from these 45 patients
were not immunostained in this series).  The 5-
year survival rates for 9 patients (excluding 1
patient who died of complications) with both
HE-negative and CK-negative nodes [HE(–),
CK(–)], for 15 patients with HE-negative but
CK-positive nodes [HE(–), CK(+)], and for 44
patients with HE-positive nodes [HE(+)] were
85.7%, 52.4% and 30.8%, respectively.  Al-
though there was no significant difference in sur-
vival between patients with HE(–) plus CK(–)
nodes and patients with HE(–) plus CK(+)
nodes, there was a statistically significant dif-
Table 3.  Relationships between immunoreactivity in lymph nodes and clinicopathological
features
     Variable                                        CK-negative                    CK-positive                    P value
                                                                 [10]                                 [15]
Age (years; mean + SD)                      58.9 + 9.8                       53.8 + 10.1 NS
Gender
Male 5 10 NS
Female 5 5
Tumor size
<7 cm 5 8 NS
>7 cm 5 7
Histology
Differentiated 4 3 NS
Undifferentiated 6 12
Depth of cancer invasion
Muscularis propria 0 4 NS
Subserosa 1 0
Serosa 9 11
Macroscopic type
1, 2 5 1 P < 0.05
3, 4 5 10
5 0 4
Lymphatic vessel invasion
Negative 7 12 NS
Positive 3 3
Blood vessel invasion
Negative 2 8 NS
Positive 8 7
[   ], number of patients.
CK, cytokeratin; NS, not significant.
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ference in survival between patients with HE(–)
and CK(–) nodes and those with HE(+) nodes
(P < 0.05).
Discussion
In the current study, we immunostained sec-
tions of 1,198 lymph nodes from 25 patients
Fig. 2.  Postoperative survival of totally gastrectomized patients with T3 or T4 gastric cancer.  HE(–), CK(–):
patients with both HE-negative and CK-negative nodes.  HE(–), CK(+): patients with HE-negative but CK-
positive nodes.  HE (+): patients with HE-positive nodes.
HE (–), CK (–)     [n = 9]   85.7%
HE (–), CK (+)   [n = 15]   52.4%
HE (+)   [n = 44]   30.8%
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who had been diagnosed previously as having
no nodal metastasis by HE staining.  Although
these 25 patients were selected from our pro-
spective study, our purpose in the present study
was to evaluate clinical implications of CK-
positive nodes.
Micrometastases in malignant tumors have
been a focus of increasing interest in recent
years because of their significance in predicting
Table 4.  Number and classification of CK-positive nodes analyzed in terms of sites of lymph
nodes
       Site of lymph nodes                                    CG 1            CG 2            CG 3             CG 4           Total
Group N1 (peri-gastric nodes)
Right cardial 6 2 1 1 10
Left cardial 0 2 0 0 2
Along the lesser curvature 8 4 2 3 17
Along the greater curvature 9 7 1 1 18
Suprapyloric 2 1 0 0 3
Infrapyloric 3 7 1 1 12
Group N2
Along the left gastric artery 4 1 0 0 5
Along the common hepatic artery 4 0 0 0 4
(anterosuperior group)
Around the celiac artery 1 0 0 0 1
At the splenic hilum 2 2 0 1 5
Around the splenic artery 1 2 0 0 3
Group N3* 0 0 0 0 0
Group N4 (paraaortic lymph nodes) 0 0 0 0 0
Total 40 28 5 7 80
* Lymph nodes along the common hepatic artery(posterior group), in the hepato-duodenal ligament, on the
posterior surface of the pancreas head, and along the superior mesenteric vein.
CG 0–4, see footnote to Table 1; CK, cytokeratin.
Cytokeratin-positive nodes in gastric cancer
111
the prognosis of patients.  Many human tumors,
such as breast (Sedmak et al., 1989), colorectal
(Sasaki et al., 1997) and gastric (Maehara et al.,
1996a; Ishida et al., 1997) cancers, are associ-
ated with such metastases in the lymph nodes or
bone marrow (Maehara et al., 1996b), which
probably affect survival.
.
 Various studies have
explored the possible application of epithelial
cell markers in the detection of micrometastases
(Trojani et al., 1987; Davison et al., 1990;
Siewert et al., 1996; Broll et al., 1997).  In addi-
tion, the predictive value of molecular or genet-
ic methods for detection of occult metastases,
which exploit polymerase chain reaction or
mutant allele-specific amplification, has been
suggested (Hayashi et al., 1994; Nakamori et
al., 1997; Nakanishi et al., 1997; Dorudi et al.,
1998).  However, it is hard to avoid false-
positive results in many cases, even though
these methods reveal occult metastases with so-
called supersensitivity.  Many investigators
have reported the results of immunostaining for
CK in bone marrow or lymph nodes and have
stressed the usefulness of this marker in the de-
tection of micrometastases from gastric cancer
(Maehara et al., 1996a, 1996b; Ishida et al.,
1997).  In the current study, we used mono-
clonal antibody CAM 5.2, which binds speci-
fically to CK peptide 8.
In our series, all sections of primary tumors
were CK-positive.  Moreover, 80 lymph nodes
(6.7%) among 1,198 nodes dissected from 15
(60%) of 25 patients, who had been diagnosed
as having no metastases by conventional HE
staining, were also CK-positive.  However, the
CK-positive nodes were confined to groups N1
or N2 and no CK-positive nodes were detected
in groups N3 and N4.  The frequency (60%) of
CK-positive nodes in our series of patients with
T3 or T4 gastric cancer was higher than the
frequency (40%) reported by Ishida and col-
leagues (1997) for patients with gastric cancer
that included T1, T2, T3 and T4 cancers, and
than the frequency (23.5%) reported by
Maehara and coworkers (1996a) for patients
with early gastric cancer.  The deep invasion of
the serosa by the tumor in all of our patients
with T3 or T4 gastric cancer might explain the
high frequency of CK-positive nodes in our
study.
As shown in this study, discrete and scatter-
ed cancer cells or small clusters of such cells are
easily overlooked after standard HE staining.
Establishment of an easy method for detecting
such small numbers of cancer cells is clinically
important.  In our study, histopathological
examination of lymph nodes was made after
only a single central cross-sectional passage.
The sensitivity of detection of metastatic depos-
its might be expected to improve significantly
by multiple sections of each node (Isozaki et al.,
1997).  In fact, second sections cut from the
lymph nodes examined in the present study
revealed metastatic deposits not only after
immunostaining but also after conventional HE
staining in 7 of the 1,198 lymph nodes.  In these
cases, metastatic cells had been undetectable on
the first section that had been stained with HE.
However, this 2-section procedure would not be
practical in routine histopathology.  Our results
suggest that immunostaining with CK-specific
antibody, in addition to conventional HE stain-
ing, would permit a more accurate diagnosis of
lymph node metastases.
Metastasis to the lymph nodes is likely to
occur together with the progression of the main
tumor.  The major risk factors for lymph node
metastasis are generally considered to be the
large size of the primary tumor, infiltrative
growth, diffuse-type gastric cancer, poor differ-
entiation and deep invasion by the primary
tumor (Kaibara et al., 1988; Maruyama et al.,
1989).  In our series, we found that a gross find-
ing of diffuse-type gastric cancer  was associ-
ated with a high frequency of CK-positive
nodes.
In our patients, the 5-year survival rate for
patients without nodal involvement [HE(–),
CK(–); 85.7%] was the highest, followed by
rates for patients with HE(–) plus CK(+) nodes
(52.4%) and for patients with HE(+) nodes
(30.8%) (Fig. 2).  Although there was no signif-
icant difference in survival between patients
with or without CK-positive nodes, perhaps
because of the small number of patients, there
was a significant difference between patients
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with HE(–) plus CK(–) nodes and patients with
HE(+) nodes.  Our results indicate that the accu-
racy of predictions of prognosis for patients
with advanced gastric cancer will be enhanced
when CK-immunostaining is performed in
combination with conventional histopathologic
analysis.
References
 1  Broll R, Schauer V, Schimmelpenning H, Strik
M, Woltmann A, Best R, et al.  Prognostic
relevance of occult tumor cells in lymph nodes of
colorectal carcinomas. Dis Colon Rectum 1997;
40:1465–1471.
 2 Davidson BR, Sams VR, Styles J, Deane C,
Boulos PB.  Detection of occult nodal metastases
in patients with colorectal carcinoma.  Cancer
1990;65:960–970.
 3 Dorudi S, Kinrade E, Marshall NC, Feakins R,
Williams NS, Bustin SA.  Genetic detection of
lymph node micrometastases in patients with
colorectal cancer.  Br J Surg 1998;85:98–100.
 4 Hayashi N, Arakawa H, Nagase H, Yanagisawa
A, Kato Y, Ohta H, et al.  Genetic diagnosis iden-
tifies occult lymph node metastases undetectable
by the histopathological method.  Cancer Res
1994;54:3853–3856.
 5 Isozaki H, Okajima K, Fujii K.  Histological eva-
luation of lymph node metastasis on serial sec-
tioning in gastric cancer with radical lympha-
denectomy.  Hepato-Gastroenterology 1997;44:
1133–1136.
 6 Ishida K, Katsuyama T, Sugiyama A, Kawasaki
S.  Immunohistochemical evaluation of lymph
node micrometastases from gastric carcinomas.
Cancer 1997;79:1069–1076.
 7 Japanese Research Society for Gastric Cancer.
The general rules for gastric cancer study. 12th
ed.  Tokyo: Kanehara Co. Ltd.; 1993.
 8 Kaibara N, Nishidoi H, Kimura O, Makino M.
Sumi K, Koga S.  Analysis of results of surgical
treatment of gastric cancer:  retrospective study
of 1,215 curatively resected cases.  Dis Surg 1988;
5:124–127.
 9 Maehara Y, Oshiro T, Endo K, Baba H, Oda S,
Ichiyoshi Y, et al. Clinical significance of occult
micrometastasis in lymph nodes from patients
with early gastric cancer who died of reccurence.
Surgery 1996;119:397–402.
10 Maehara Y, Yamamoto M, Oda S. Baba H,
Kusumoto T, Ohno S, et al.  Cytokeratin-positive
cells in bone marrow for identifying distant
micrometastasis of gastric cancer.  Br J Cancer
1996;73:83–87.
11 Makin C, Bodmer W.  Monoclonal antibody to
cytokeratin for use in routine histopathology.  J
Clin Pathol 1984;37:975–983.
12 Maruyama K, Gunven P, Okabayashi K, Sasako
M, Kinoshita T.  Lymph node metastases of gas-
tric cancer:  general pattern in 1,931 patients.
Ann Surg 1989;210:596–602.
13 Nakamori S, Kameyama M, Furukawa H, Takeda
O, Sugai S, Imaoka S, et al.  Genetic detection of
colorectal cancer cells in circulation and lymph
nodes.  Dis Colon Rectum 1997;40:S29–S35.
14 Nakanishi H, Kodera Y, Torii A, Hirai T,
Yamamura Y, Kato T, et al.  Detection of carcino-
embryonic antigen-expressing free tumor cells in
peritoneal washes from patients with gastric can-
cer by polymerase chain reaction.  Jpn J Cancer
1997;88:687–692.
15 Sasaki M, Watanabe H, Jass JR, Ajioka Y,
Kobayashi M, Matsuda K, et al.  Occult lymph
node metastases detected by cytokeratin im-
munohistochemistry predict recurrence in “node-
negative” colorectal cancer.  J Gastroenterol
1997;32:758–764.
16 Sedmak DD, Meineke TA, Knechtges DS.
Detection of metastatic breast carcinoma with
monoclonal antibodies to cytokeratins.  Arch
Pathol Lab Med 1989;113:786–789.
17 Siewert JR, Kestlmeier R, Busch R, Bottcher K,
Roder JD, Muller J, et al.  Benefits of D2 lymph
node dissection for patients with gastric cancer
and pN0 and pN1 lymph node metastases.  Br J
Surg 1996;83:1144–1147.
18 Trojani M, Mascare I, Bonichon F, Coindre JM,
Delsol G.  Micrometastases to axillary lymph
nodes from carcinoma of breast:  detection by
immunohistochemistry and  prognostic signifi-
cance.  Br J Cancer 1987;55:303–306.
20 Yonemera Y, Katayama K, Kamata T, Fushida S,
Segawa M, Ooyama S, et al. Surgical treatment of
advanced gastric cancer with metastasis in para-
aortic lymph nodes.  Int Surg 1991;76:222–225.
(Received September 29, Accepted October 13, 1998)
